Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.610
0.00 (0.00%)
At close: Dec 24, 2025, 4:00 PM EST
1.650
+0.040 (2.48%)
Pre-market: Dec 26, 2025, 5:11 AM EST
Equillium Market Cap
Equillium has a market cap or net worth of $98.04 million as of December 26, 2025. Its market cap has increased by 279.62% in one year.
Market Cap
98.04M
Enterprise Value
65.66M
1-Year Change
279.62%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $98.04M, a decrease of -58.20%. That is a compound annual growth rate of -11.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 98.04M | 269.83% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | 132.29M | 125.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |